Aim: Rheumatoid arthritis (RA) as an inflammatory autoimmune disease affects the synovial joints as well as other organs and tissues. Since aberrant expression of MIC molecules has been observed in RA patient, MIC genotypes might play certain roles in the development of RA.
INTRODUCTION
Rheumatoid arthritis (RA) as an inflammatory autoimmune disease affects the synovial joints as well as other organs and tissues. The progression of RA could cause joint deterioration. The incidence of RA is approximately 0.3-1.1% worldwide and the ratio of female patients to male patients is 3 : 1. 1 The cause of RA is multifactorial and includes both genetic and environmental factors. The main environmental factors are infection, diet, pollutants, smoking as well as birth weight. 1 The genetic factors associated with RA development include both human leukocyte antigen (HLA) and non-HLA genes. HLA loci account for~50% of the genetic predisposition to RA. 2 The polymorphisms and expression levels of several immune-related genes, such as TCR-CD3f gene 3 and IL-13 gene, 4 could affect the pathogenesis of RA. A few HLA alleles, such as HLA-DRB1, 5 have also been proven as a risk for developing RA. The odds ratio of HLA-DRB1 alleles varies across ethnic groups. 6, 7 Besides HLA-associated genetic predisposition, skewed X chromosome inactivation could also serve as a synergic risk factor. 8 Gene polymorphisms of neuropeptide S receptor 1, 9 interferon regulatory factor 5, 10 signal transducer and activator of transcription 4 (STAT4), cytotoxic T-lymphocyte protein 4 (CTLA4) 11 and so on, were proven to be associated with RA susceptibility. Since both lifestyle and genetic lineage might affect RA development, a study focused on a single ethnic group would be easier to reveal the clues for disease susceptibility. In our study, the MICA/MICB genotypes of Han Chinese in Hainan Island (geographically separated from the China mainland) were analyzed.
MICA protein is coded by 6 exons of MICA, and it is the ligand of NKG2D (killer cell C-type lectin-like receptors, subfamily D) which are expressed on human natural killer (NK) cells, cd T cells, and cytotoxic T cells. The activation of NKG2D by MICA molecules leads to the responses of cytotoxicity, cell proliferation and cytokine production. According to the IMGT/HLA Database, 101 human MICA alleles and 41 human MICB alleles have been documented. 12 Based on the triplet repeat units in exon 5 of MICA gene (transmembrane region), seven MICA STR alleles (A4-A10) with different units of a trinucleotide repeat (GCT/AGC) have been identified. 13, 14 Allele A5.1 with five repetitions carries an additional G/ C insertion in exon 5. The polymorphism of MICA could serve as functional variants with different binding affinity to NKG2D. Elevated NKG2D activity might modulate effector T cell and promote autoimmune reaction. The aberrant expression of MIC molecules has been observed in RA patients 15 . The down-regulation of NKG2D by soluble MICA or MICB has also been proven. 16 Therefore, we hypothesized that MIC gene polymorphisms might be associated with susceptibility to RA. 
MATERIALS AND METHODS

Subjects and samples
DNA preparation and MIC genotyping
Tubes containing ethylenediaminetetraacetic acid (EDTA) were used to collect peripheral blood samples of subjects. A routine salting out method was conducted for blood sample DNA extraction and purification. Polymerase chain reaction (PCR) sequencespecific priming and sequence-based typing techniques were carried out to amplify MICA exons 2-5 as well as the internal control, human growth hormone gene. The genetic diversity of short tandem repeat sequence of MICA exon 5 (MICA-STR) was also examined. The experimental procedure was previously published. 17 Except intronic variation alleles, 55 MICA alleles and 19 MICB alleles were detected and amplified using a set of 95 primers. 18 The MIC genotype information was obtained from the IMGT/HLA database.
The PCR mixture contained 40 ng template DNA and 0.1 lmol/L primers. The PCR amplification was performed on an Eppendorf Mastercycler 5333 thermocycler (Hamburg, Germany) using the following conditions: 94°C for 4 min, then 10 cycles of 94°C for 30 s, 65°C for 50 s and 72°C for 20 s, followed by a final elongation at 72°C for 8 min. DNA products were separated on a 2% agarose gel, stained with ethidium bromide and visualized using an UV transilluminator. The PCR products were then sequenced with BigDye Terminator v3.1 Cycle Sequence kit (Axygen Biosciences, Union City, CA, USA).
Statistical analysis
The MICA/MICB allele frequency difference between RA patients and healthy controls were analyzed using SHESIS software. 19 Chi-square test was performed for statistical analysis of MIC gene polymorphism and RA Alleles MICB*002 and MICB*014 were negatively associated with RA in Hainan Han Chinese MICB polymorphisms and allele frequencies in RA patients and healthy controls are listed in Table 3 . The allelic distributions of MICB were consistent with Hardy-Weinberg equilibrium proportions. In the studied population, the allele with the highest frequency was MICB*005:02 (47.90%, 296/618) followed by allele MICB*002 (18.61%, 115/618). MICB*007 was the allele with the lowest frequency, which was only present in five out of 618 tested alleles (0.81%). MICB*002 and MICB*014 allelic frequencies in the healthy group were significantly higher, indicating their protective role against RA (P = 0.000, 0.005; corrected P = 0.00, 0.05). MICB*009N was more frequent in RA patients than in healthy controls (7.0% vs. 2.6%), but no significant differences were found. MICB*002 and MICB*014 alleles share most of the polymorphic sites. However, MICB*014 contains a serine at residue 268 rather than a glycine, and MICB*014 is 66 residues shorter than MICB*002.
The linkage disequilibrium analysis between MICA and MICB in the studied population is shown in Table 4 
DISCUSSION
This RA susceptibility study on Han Chinese in Hainan Island showed a significant correlation between RA and certain MICA or MICB alleles. Based on this study, MICA*009 and MICA*A6 might be important alleles related to RA. Carrying those two alleles could increase the risk of RA development, whereas, MICB*002 and MICB*014 conferred protection against RA. In the above association study, highly significant corrected P-values were obtained. The major polymorphic sites that discriminated MICB*002 and MICB*014 from other genotypes are highlighted in the illustration of MICB structure (Fig. 1b) , such as 57E and 113N in the gene product of MICB*002, and 268S as well as N-terminal and C-terminal deletion in the gene product of MICB*014.
The results of MIC gene polymorphisms in Han Chinese RA patients indicated that the presence of MICA*009 increased the risk of RA development. The major polymorphic sites distinguishing MICA*009 from other genotypes detected in the present study are 122V and the insertion of 298A (Fig 1a) . MICA*027 was also higher in the RA group. Since only four patients were found to carry MICA*027, a reliable conclusion was not able to be drawn. In the studied subjects, the gene frequency of MICA*027 was only 0.65% (4/618). According to a previous study, the gene frequency of MICA*027 in a Han Chinese population from Zhejiang province in mainland China was 7%. 20 The difference might be due to the geographic variation of two different Han Chinese populations, especially the difference between Han Chinese in Hainan Island and the mainland.
In comparison with a previous study of MICA in association with RA, Martinez et al. 21 found MICA*A6 was protective against RA in a Spanish population. This conclusion was supported by another study on 90 RA and 85 healthy Caucasian subjects. 22 However, a study with a larger sample size with a Caucasian population did not prove any association between MICA*A6 and RA. 23 In our study on a Han Chinese population, MICA*A6 was a risk factor for RA while MICB*002 and MICB*014 were suggested to be protective against RA. It is possible that different NKG2D polymorphisms might enhance or counteract the effect caused by MICA polymorphic change. Therefore, it is worth considering the NKG2D polymorphism when studying the MICA polymorphism and disease susceptibility. In a future study, if bigger sample sizes can be achieved, classification of RA patients into anti-cyclic citrullinated peptide antibody (ACPA) and rheumatoid factor (RF), the two subsets may facilitate a disease association study. Similar studies in various ethnic groups also benefit accurate association of MIC gene polymorphism with RA disease. The understanding of individual genetic background and variation might also help us determine while MICB*002 and MICB*014 provide a protective role against RA.
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